AGREEMENT AND PLAN OF MERGER dated as of March 14, 2012 by and among SHIRE PHARMACEUTICALS LLC, PELEGRINA CORPORATION, FERROKIN BIOSCIENCES, INC. and SHAREHOLDER REPRESENTATIVE SERVICES LLC, as the Equityholders’ RepresentativeMerger Agreement • May 23rd, 2012 • Shire PLC • Pharmaceutical preparations • Delaware
Contract Type FiledMay 23rd, 2012 Company Industry JurisdictionTHIS AGREEMENT AND PLAN OF MERGER (this “Agreement”) is made and entered into as of March 14, 2012 by and among SHIRE PHARMACEUTICALS LLC, a Delaware limited liability company (“Parent”), PELEGRINA CORPORATION, a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”), FERROKIN BIOSCIENCES, INC., a Delaware corporation (the “Company”), and SHAREHOLDER REPRESENTATIVE SERVICES LLC, a Colorado limited liability company, solely in its capacity as the Equityholders’ Representative (the “Equityholders’ Representative”).